首页> 美国卫生研究院文献>Critical Care >Year in review 2007: Critical Care – nephrology
【2h】

Year in review 2007: Critical Care – nephrology

机译:年度回顾2007:重症监护–肾脏病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We summarize original research in the field of critical care nephrology that was accepted for publication or published in 2007 in Critical Care and, when considered relevant or directly linked to this research, in other journals. Four main topics were identified for a brief overview. The first of these was the definition of acute kidney injury and recent evidence showing the validity of RIFLE (Risk, Injury, Failure, Loss and End-stage kidney disease) criteria and the recent Acute Kidney Injury Network review of the same criteria. Second, we cover the clinical and experimental utilization of novel biomarkers for diagnosis of acute kidney injury, giving special attention to neutrophil gelatinase-associated lipocalin protein. The third area selected for review is outcomes of acute kidney injury during the past 10 years, described by a recent Austrailian epidemiological study. Finally, specific technical features of renal replacement therapies were examined in 2007, specifically regarding anticoagulation and vascular access.
机译:我们总结了重症监护肾病学领域的原始研究,该研究已于2007年在《重症监护》中发表或发表,并被认为与该研究相关或直接关联于其他期刊。确定了四个主要主题,以进行简要概述。首先是急性肾损伤的定义,最近的证据显示了RIFLE(风险,伤害,衰竭,丧失和终末期肾脏疾病)标准的有效性,以及最近急性肾损伤网络对该标准的审查。其次,我们涵盖了新型生物标志物在诊断急性肾损伤中的临床和实验应用,并特别关注中性粒细胞明胶酶相关的脂蛋白的蛋白。一项最近进行的奥地利流行病学研究描述,选择进行审查的第三个领域是过去10年中急性肾损伤的预后。最后,在2007年检查了肾脏替代疗法的具体技术特征,特别是关于抗凝和血管通路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号